» Articles » PMID: 20578714

Isolation, Structure Elucidation, and Synergistic Antibacterial Activity of a Novel Two-component Lantibiotic Lichenicidin from Bacillus Licheniformis VK21

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2010 Jun 29
PMID 20578714
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

A novel synergetic lantibiotic pair, Lchalpha (3249.51 Da) and Lchbeta (3019.36 Da), termed lichenicidin VK21, was isolated from the producer strain Bacillus licheniformis VK21. Chemical and spatial structures of Lchalpha and Lchbeta were determined. Each peptide contains 31 amino acid residues linked by 4 intramolecular thioether bridges and the N-terminal 2-oxobutyryl group. Spatial structures of Lchalpha and Lchbeta were studied by NMR spectroscopy in methanol solution. The Lchalpha peptide displays structural homology with mersacidin-like lantibiotics and involves relatively well-structured N- and C-terminal domains connected by a flexible loop stabilized by a thioether bridge Ala11-S-Ala21. In contrast, the Lchbeta peptide represents a prolonged hydrophobic alpha-helix flanked with more flexible N- and C-terminal domains. A lantibiotic cluster of the Bacillus licheniformis VK21 genome which comprises the structural genes, lchA1 and lchA2, encoding the lantibiotics precursors, as well as the gene of a modifying enzyme lchM1, was amplified and sequenced. The mature peptides, Lchalpha and Lchbeta, interact synergistically to possess antibiotic activity against Gram-positive bacteria within a nanomolar concentration range, though the individual peptides were shown to be active at micromolar concentrations. Our results afford molecular insight into the mechanism of lichenicidin VK21 action.

Citing Articles

Whole genome sequence and LC-Mass for identifying antimicrobial metabolites of Bacillus licheniformis endophyte.

Soliman N, Abbas A, El Tayeb W, Alshahrani M, Aboshanab K AMB Express. 2024; 14(1):139.

PMID: 39704988 PMC: 11662132. DOI: 10.1186/s13568-024-01789-y.


Bibacillin 1: a two-component lantibiotic from .

Moreira R, Yang Y, Luo Y, Gilmore M, van der Donk W RSC Chem Biol. 2024; .

PMID: 39268544 PMC: 11385697. DOI: 10.1039/d4cb00192c.


Heterologous biosynthesis of myxobacterial lanthipeptides melittapeptins.

Kaweewan I, Mukai K, Rukthanapitak P, Nakagawa H, Hosaka T, Kodani S Appl Microbiol Biotechnol. 2024; 108(1):122.

PMID: 38229328 DOI: 10.1007/s00253-023-12834-4.


: A Producer of Antimicrobial Substances, including Antimycobacterials, Which Are Feasible for Medical Applications.

Shleeva M, Kondratieva D, Kaprelyants A Pharmaceutics. 2023; 15(7).

PMID: 37514078 PMC: 10383908. DOI: 10.3390/pharmaceutics15071893.


Antimicrobial Peptide Synergies for Fighting Infectious Diseases.

Mhlongo J, Waddad A, Albericio F, de la Torre B Adv Sci (Weinh). 2023; 10(26):e2300472.

PMID: 37407512 PMC: 10502873. DOI: 10.1002/advs.202300472.